111 related articles for article (PubMed ID: 12151764)
1. Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease.
Lai MK; Tsang SW; Francis PT; Keene J; Hope T; Esiri MM; Spence I; Chen CP
Neuroreport; 2002 Jul; 13(9):1175-8. PubMed ID: 12151764
[TBL] [Abstract][Full Text] [Related]
2. Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease.
Lai MK; Tsang SW; Francis PT; Esiri MM; Keene J; Hope T; Chen CP
Brain Res; 2003 Jun; 974(1-2):82-7. PubMed ID: 12742626
[TBL] [Abstract][Full Text] [Related]
3. [3H]GR113808 binding to serotonin 5-HT(4) receptors in the postmortem neocortex of Alzheimer disease: a clinicopathological study.
Lai MK; Tsang SW; Francis PT; Esiri MM; Hope T; Lai OF; Spence I; Chen CP
J Neural Transm (Vienna); 2003 Jul; 110(7):779-88. PubMed ID: 12811638
[TBL] [Abstract][Full Text] [Related]
4. Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease.
Garcia-Alloza M; Hirst WD; Chen CP; Lasheras B; Francis PT; Ramírez MJ
Neuropsychopharmacology; 2004 Feb; 29(2):410-6. PubMed ID: 14571255
[TBL] [Abstract][Full Text] [Related]
5. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
Peng S; Wuu J; Mufson EJ; Fahnestock M
J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
[TBL] [Abstract][Full Text] [Related]
6. Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease.
Lai MK; Tsang SW; Alder JT; Keene J; Hope T; Esiri MM; Francis PT; Chen CP
Psychopharmacology (Berl); 2005 May; 179(3):673-7. PubMed ID: 15551121
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
Casanovas JM; Vilaró MT; Mengod G; Artigas F
J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
[TBL] [Abstract][Full Text] [Related]
8. Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin in normal and Alzheimer brain.
Middlemiss DN; Palmer AM; Edel N; Bowen DM
J Neurochem; 1986 Mar; 46(3):993-6. PubMed ID: 2419502
[TBL] [Abstract][Full Text] [Related]
9. Quantitative subregional distribution of serotonin1A receptors and serotonin transporters in the human dorsal raphe.
Stockmeier CA; Shapiro LA; Haycock JW; Thompson PA; Lowy MT
Brain Res; 1996 Jul; 727(1-2):1-12. PubMed ID: 8842377
[TBL] [Abstract][Full Text] [Related]
10. Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia.
Sumiyoshi T; Stockmeier CA; Overholser JC; Dilley GE; Meltzer HY
Brain Res; 1996 Feb; 708(1-2):209-14. PubMed ID: 8720882
[TBL] [Abstract][Full Text] [Related]
11. A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease.
Tsang SW; Keene J; Hope T; Spence I; Francis PT; Wong PT; Chen CP; Lai MK
J Neurol Sci; 2010 Jan; 288(1-2):151-5. PubMed ID: 19818455
[TBL] [Abstract][Full Text] [Related]
12. Post-synaptic 5-HT1A and 5-HT2A receptors are increased in Parkinson's disease neocortex.
Chen CP; Alder JT; Bray L; Kingsbury AE; Francis PT; Foster OJ
Ann N Y Acad Sci; 1998 Dec; 861():288-9. PubMed ID: 9928295
[No Abstract] [Full Text] [Related]
13. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
14. A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease.
Shinno H; Inagaki T; Miyaoka T; Okazaki S; Kawamukai T; Utani E; Inami Y; Horiguchi J
J Neurol Sci; 2007 Sep; 260(1-2):132-8. PubMed ID: 17540407
[TBL] [Abstract][Full Text] [Related]
15. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
[TBL] [Abstract][Full Text] [Related]
16. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice.
Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW
J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723
[TBL] [Abstract][Full Text] [Related]
17. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
[TBL] [Abstract][Full Text] [Related]
18. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
Sumiyoshi T; Ichikawa J; Meltzer HY
Neuropsychopharmacology; 1997 Mar; 16(3):183-90. PubMed ID: 9138434
[TBL] [Abstract][Full Text] [Related]
19. Agonist-promoted down-regulation and functional desensitization in two naturally occurring variants of the human serotonin1A receptor.
Rotondo A; Nielsen DA; Nakhai B; Hulihan-Giblin B; Bolos A; Goldman D
Neuropsychopharmacology; 1997 Jul; 17(1):18-26. PubMed ID: 9194046
[TBL] [Abstract][Full Text] [Related]
20. Involvement of 5-HT1A receptors in the consolidation of learning in cognitively impaired rats.
Meneses A; Terrón JA; Hong E
Ann N Y Acad Sci; 1998 Dec; 861():286-7. PubMed ID: 9928294
[No Abstract] [Full Text] [Related]
[Next] [New Search]
